Products for Research Use Only

Sulfamethoxazole

CAT: 0804-HY-B0322-01Size: 100 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-B0322-01Size:100 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Sulfamethoxazole (Ro 4-2130) is a sulfonamide antibiotic with a widespread antibacterial activity. Sulfamethoxazole inhibits bacterial folate metabolism by competing with 4-Aminobenzoic acid (PABA) to act on dihydropteroate synthetase and dihydropteroate reductase. Sulfamethoxazole can be used for the study of urinary tract infections (UTIs), prostatitis, and bronchitis[1][2][3].
CAS Number
723-46-6
Product Name Alternative
Ro 4-2130
UNSPSC
12352005
Hazard Statement
H303, H317, H361
Target
Antibiotic; Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection; Cancer
Assay Protocol
https://www.medchemexpress.com/Sulfamethoxazole.html
Purity
99.91
Solubility
DMSO : ≥ 100 mg/mL|H2O : < 0.1 mg/mL
Smiles
O=S(C1=CC=C(N)C=C1)(NC2=NOC(C)=C2)=O
Molecular Formula
C10H11N3O3S
Molecular Weight
253.28
Precautions
H303, H317, H361
References & Citations
[1]Zambuzzi-Carvalho et al. Transcriptional profile of the human pathogenic fungus Paracoccidioides lutzii in response to sulfamethoxazole. Med Mycol. 2015;53 (5) :477-492. |[2]Choonara BF, et al. A menthol-based solid dispersion technique for enhanced solubility and dissolution of sulfamethoxazole from an oral tablet matrix. AAPS PharmSciTech. 2015 Aug;16 (4) :771-86.|[3]Ogata H, et al. Dose Dependent Effect of Sulfamethoxazole on Inhibiting KATP Channel of Mouse Pancreatic β Cell. Dose Response. 2023 Sep 28;21 (3) :15593258231203611.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Citation 01
ACS Environ Au. 2025 Aug 8.|Anal Chem. 2025 Jun 3;97 (21) :11099-11109.|Autophagy. 2023 Oct;19 (10) :2702-2718.|Bioresour Technol Rep. 2023 Dec, 24, 101619.|bioRxiv. 2024 May 10.|bioRxiv. 2025 January 19.|Chemosphere. 2019 Jun:225:378-387.|Clean Technol Environ Policy. 2025 May 22.|Clin Chem. 2019 Dec;65 (12) :1522-1531. |Ecotoxicol Environ Saf. 2023 Mar 15:253:114711.|Eur J Clin Microbiol Infect Dis. 2025 Sep 29.|Microorganisms. 2025 Apr 18;13 (4) :938.|Pharmaceutics. 2025 Mar 26;17 (4) :423.|Signal Transduct Target Ther. 2023 Sep 18;8 (1) :353.|Water Res. 2023 Jul 15:240:120110.|Water. 2025 Jun 6.|Nat Commun. 2022 Mar 2;13 (1) :1116.